GPT and metabolic dysfunction-associated steatohepatitis: Although semaglutide improved body weight, plasma ALT levels and hepatic steatosis, liver stiffness determined by magnetic resonance elastography was unchanged compared to placebo-treated NASH patients with NASH-related cirrhosis (stage 4 fibrosis) [40].